Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Proteome Sciences, Meso Scale Discovery

Premium

Proteome Sciences had released its new β-amyloid mass spec workflow for quantification of Aβ species in cerebrospinal fluid.

The workflow is intended for research use and early stage clinical trial work and can detect and quantify 14 different Aβ species above 0.5 ng/ml with coefficients of variation of less than 20 percent, the company said.


Meso Scale Discovery has launched its V-PLEX biomarker tests, a line of validated immunoassays for clinical research.

Based on MSD's electrochemiluminescence Multi-Array technology, the assays focus on emerging biomarkers typically not available on traditional diagnostics platforms, the company said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.